Cardiomyocyte marker expression in dogs with left atrial enlargement due to dilated cardiomyopathy or myxomatous mitral valve disease | Zendy

I. Janus | Zendy; M. Kandefer-Gola | Zendy; R. Ciaputa | Zendy; Agnieszka Noszczyk-Nowak | Zendy; Urszula Pasławska | Zendy; Massimiliano Tursi | Zendy; Marcin Nowak | Zendy

Open Access

Cardiomyocyte marker expression in dogs with left atrial enlargement due to dilated cardiomyopathy or myxomatous mitral valve disease

Author(s) -

I. Janus,

M. Kandefer-Gola,

R. Ciaputa,

Agnieszka Noszczyk-Nowak,

Urszula Pasławska,

Massimiliano Tursi,

Marcin Nowak

Publication year - 2017

Publication title -

folia histochemica et cytobiologica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.384

H-Index - 40

eISSN - 1897-5631

pISSN - 0239-8508

DOI - 10.5603/fhc.a2017.0009

Subject(s) - dilated cardiomyopathy , medicine , pathogenesis , cardiology , dystrophin , cardiomyopathy , left atrial enlargement , heart failure , muscular dystrophy , atrial fibrillation , sinus rhythm

Dilated cardiomyopathy (DCM) and myxomatous mitral valve disease (MMVD) are common heart conditions in dogs. They have different etiology and pathogenesis and although other studies focused on changes in the left ventricles of the affected hearts, the aim of our study was to assess the expressions of some intrinsic proteins in the enlarged left atria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research